Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.

Journal of virological methods - 1 Jun 2024

Neufeld Bronwyn, Munyuza Chantal, Reimer Alexandria, Capiña Rupert, Lee Emma R, Becker Marissa, Sandstrom Paul, Ji Hezhao, Cholette François

Abstract excerpt

Despite increasing scale-up of antiretroviral therapy (ART) coverage, challenges related to adherence and HIV drug resistance (HIVDR) remain. The high cost of HIVDR surveillance is a persistent challenge with implementation in resource-constrained settings. Dried blood spot (DBS) specimens have been demonstrated to be a feasible alternative to plasma or serum for HIVDR genotyping and are more suitable for lower...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Dried Blood Spot Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genotyping Techniques

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Specimen Handling

Share to Viral Load

Source

Identifiers

PMID: 38604585
DOI: 10.1016/j.jviromet.2024.114939

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.PMID 38604585Read ↗

Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.Semantic proximity Read ↗

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Semantic proximity Read ↗

Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral TherapySemantic proximity Read ↗

Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.Semantic proximity Read ↗

Genotypic testing for HIV-1 drug resistance using dried blood samples.Semantic proximity Read ↗

HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.Semantic proximity Read ↗

HIV-2 Drug Resistance Genotyping from Dried Blood Spots.Semantic proximity Read ↗

Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistanceSemantic proximity Read ↗

HIV-1 drug resistance surveillance using dried whole blood spots.Semantic proximity Read ↗

Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.Semantic proximity Read ↗

Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.Semantic proximity Read ↗

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.